Oren Livnat

Stock Analyst at HC Wainwright & Co.

(3.65)
# 751
Out of 4,893 analysts
140
Total ratings
45.14%
Success rate
7.8%
Average return

Stocks Rated by Oren Livnat

Pacira BioSciences
Apr 8, 2025
Maintains: Buy
Price Target: $48$65
Current: $23.17
Upside: +180.54%
Verrica Pharmaceuticals
Apr 8, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.82
Upside: -
Collegium Pharmaceutical
Mar 24, 2025
Reiterates: Buy
Price Target: $50
Current: $32.35
Upside: +54.56%
Trevi Therapeutics
Mar 19, 2025
Reiterates: Buy
Price Target: $13
Current: $6.17
Upside: +102.59%
ANI Pharmaceuticals
Mar 17, 2025
Reiterates: Buy
Price Target: $94
Current: $65.39
Upside: +43.76%
Zevra Therapeutics
Mar 13, 2025
Reiterates: Buy
Price Target: $20
Current: $11.56
Upside: +73.01%
Jazz Pharmaceuticals
Mar 10, 2025
Maintains: Buy
Price Target: $200$217
Current: $111.60
Upside: +94.44%
Xeris Biopharma Holdings
Mar 7, 2025
Reiterates: Buy
Price Target: $6.6$8
Current: $5.34
Upside: +49.81%
Avadel Pharmaceuticals
Mar 4, 2025
Reiterates: Buy
Price Target: $21
Current: $9.55
Upside: +119.90%
Tarsus Pharmaceuticals
Feb 26, 2025
Reiterates: Buy
Price Target: $73
Current: $41.25
Upside: +76.97%
Reiterates: Buy
Price Target: $12
Current: $3.07
Upside: +291.52%
Reiterates: Buy
Price Target: $7.5
Current: $3.82
Upside: +96.34%
Maintains: Buy
Price Target: $14$8
Current: $0.69
Upside: +1,062.12%
Maintains: Buy
Price Target: $43$60
Current: $3.21
Upside: +1,755.49%
Maintains: Buy
Price Target: $252$198
Current: $1.44
Upside: +13,650.00%